RIM
TECH icon

Redpoint Investment Management’s Bio-Techne TECH Stock Holding History

Redpoint Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$270K Hold
3,800
– – 0.04% 490
2022
Q2 		$329K Hold
3,800
– – 0.04% 487
2022
Q1 		$411K Buy
3,800
+1,140
+43% +$118K 0.04% 477
2021
Q4 		$344K Buy
2,660
+1,000
+60% +$123K 0.03% 543
2021
Q3 		$201K Buy
+1,660
New +$202K 0.02% 636

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Redpoint Investment Management's TECH Position: Q3 2022 in Review

Redpoint Investment Management held its Bio-Techne (TECH) position steady in Q3 2022 at 3,800 shares worth $270K. The position accounts for 0.04% of the portfolio, ranked #490.

Redpoint Investment Management first reported a position in TECH in Q3 2021 and has held it in 5 quarters since. The position peaked at $411K in Q1 2022. 535 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Redpoint Investment Management held 3,800 shares of Bio-Techne worth $270K as of Q3 2022.
  • Redpoint Investment Management left its Bio-Techne share count unchanged in Q3 2022.
  • Bio-Techne made up 0.04% of Redpoint Investment Management's portfolio in Q3 2022, its #490 holding.
  • Redpoint Investment Management first reported a position in Bio-Techne in Q3 2021 and has held it in 5 quarters since.
  • Redpoint Investment Management's Bio-Techne position peaked at $411K in Q1 2022.
  • 535 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Redpoint Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.